1226 - 1250 of 6564 Results
Title
Year
-
OPENTitle: The commercial genetic testing landscape for Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 107End Page: 111Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.001Best OA location URL: http://www.prd-journal.com/article/S1353802021003564/pdfCitation Count: 29
-
OPENTitle: Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variantJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 69Issue #:Start Page: 103125End Page: 103125Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2023.103125Best OA location URL: https://doi.org/10.1016/j.scr.2023.103125Citation Count: 4
-
OPENTitle: An Increased Burden of Highly Active Retrotransposition Competent L1s Is Associated with Parkinson’s Disease Risk and Progression in the PPMI CohortJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 21Issue #: 18Start Page: 6562End Page: 6562Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms21186562Best OA location URL: https://www.mdpi.com/1422-0067/21/18/6562/pdfCitation Count: 43
-
OPENTitle: Screening for impulse control symptoms in patients with de novo Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 2Start Page: 176End Page: 180Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31827b915cBest OA location URL: https://n.neurology.org/content/neurology/80/2/176.full.pdfCitation Count: 189
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease2016OPENTitle: Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 7End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0072-9Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0072-9Citation Count: 290
-
OPENTitle: Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severityJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page: 7End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-015-0185-3Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-015-0185-3Citation Count: 94
-
OPENTitle: Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s diseaseJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 164End Page: 164Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-017-0935-1Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-017-0935-1Citation Count: 105
- The Luxembourg Parkinson’s Study: A Comprehensive Approach for Stratification and Early Diagnosis2018OPENTitle: The Luxembourg Parkinson’s Study: A Comprehensive Approach for Stratification and Early DiagnosisJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page: 326End Page: 326Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2018.00326Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2018.00326/pdfCitation Count: 98
-
OPENTitle: Parkinson’s Disease–Mild Cognitive Impairment (PD-MCI): A Useful Summary of Update KnowledgeJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page: 303End Page: 303Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2019.00303Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2019.00303/pdfCitation Count: 48
-
OPENTitle: Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP)Journal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page: 553635End Page: 553635Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.553635Best OA location URL: https://escholarship.org/uc/item/46x4b7c2Citation Count: 36
-
OPENTitle: Recruitment for Remote Decentralized Studies in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 371End Page: 380Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212935Best OA location URL: https://escholarship.org/uc/item/0k98f47rCitation Count: 22
- Quantitative Digitography Measures Motor Symptoms and Disease Progression in Parkinson’s Disease2022OPENTitle: Quantitative Digitography Measures Motor Symptoms and Disease Progression in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 6Start Page: 1979End Page: 1990Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-223264Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223264?id=journal-of-parkinsons-disease%2Fjpd223264Citation Count: 16
-
OPENTitle: GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting CompoundsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 8Issue #:Start Page: 562522End Page: 562522Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2020.562522Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcell.2020.562522/pdfCitation Count: 13
-
OPENTitle: Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 6Issue #:Start Page: 53End Page: 53Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2014.00053Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2014.00053/pdfCitation Count: 171
-
OPENTitle: Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriersJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 6Issue #:Start Page: 248End Page: 248Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2014.00248Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2014.00248/pdfCitation Count: 77
- Distinct Role of Striatal Functional Connectivity and Dopaminergic Loss in Parkinson’s Symptoms2017OPENTitle: Distinct Role of Striatal Functional Connectivity and Dopaminergic Loss in Parkinson’s SymptomsJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page: 151End Page: 151Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2017.00151Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2017.00151/pdfCitation Count: 16
-
OPENTitle: Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease 1Journal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 5Issue #: 3Start Page: 581End Page: 594Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-150570Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd150570?id=journal-of-parkinsons-disease%2Fjpd150570Citation Count: 30
-
OPENTitle: Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 5Issue #: 4Start Page: 783End Page: 792Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-150682Best OA location URL: http://doi.org/10.3233/JPD-150682Citation Count: 46
-
OPENTitle: Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)Journal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 8Issue #: 4Start Page: 517End Page: 527Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181434Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/137434Citation Count: 24
-
OPENTitle: A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-SynucleinJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 1Start Page: 31End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181471Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181471?id=journal-of-parkinsons-disease%2Fjpd181471Citation Count: 57
-
OPENTitle: The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson’s DiseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 9Issue #: 3Start Page: 553End Page: 563Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191648Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191648?id=journal-of-parkinsons-disease%2Fjpd191648Citation Count: 44
-
OPENTitle: Ten Years of the International Parkinson Disease Genomics Consortium: Progress and Next StepsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 10Issue #: 1Start Page: 19End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191854Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191854?id=journal-of-parkinsons-disease%2Fjpd191854Citation Count: 33
-
OPENTitle: Clinical Progression of Parkinson’s Disease: Insights from the NINDS Common Data ElementsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1075End Page: 1085Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-201932Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8177750Citation Count: 31
-
OPENTitle: Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson’s Disease in the Harvard Biomarkers StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 505End Page: 510Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-191882Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7416447Citation Count: 43
- Entorhinal Cortex Atrophy in Early, Drug-naive Parkinson’s Disease with Mild Cognitive Impairment2018OPENTitle: Entorhinal Cortex Atrophy in Early, Drug-naive Parkinson’s Disease with Mild Cognitive ImpairmentJournal Name: Aging and diseasePublisher: Aging and DiseaseVol: 10Issue #: 6Start Page: 1221End Page: 1221Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14336/ad.2018.1116Best OA location URL: http://www.aginganddisease.org/EN/article/downloadArticleFile.do?attachType=PDF&id=147799Citation Count: 47